IL-37 mitigates liver inflammation and alleviates liver fibrosis by inhibiting the expression of pro-inflammatory cytokines and chemokines in hepatocytes and KCs, reducing neutrophil activity, and acting directly on hepatocytes. Here, TBCE is linked to Hepatic fibrosis.